Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus

被引:0
|
作者
Man Li
Lei Duan
Yulun Cai
Benchuan Hao
Jianqiao Chen
Huiying Li
Hongbin Liu
机构
[1] Chinese PLA General Hospital,Department of Cardiology, The Second Medical Center
[2] Beijing Key Laboratory of Chronic Heart Failure Precision Medicine,undefined
来源
关键词
sST2; Coronary artery disease; Atherosclerosis; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus
    Li, Man
    Duan, Lei
    Cai, Yulun
    Hao, Benchuan
    Chen, Jianqiao
    Li, Huiying
    Liu, Hongbin
    [J]. CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [2] The value of soluble suppression of tumorigenesis-2 (sST2) in the maintenance of hemodialysis patients with heart failure
    Zhou, X.
    Yi, F.
    Peng, L.
    Jiang, J.
    Lan, L.
    [J]. HIPPOKRATIA, 2022, 26 (01) : 19 - 24
  • [3] Prognostic value of sST2 in heart failure patients with diabetes
    Castiglione, V.
    Chiriaco', M.
    Aimo, A.
    Januzzi, J.
    Richards, A. M.
    Lam, C. S. P.
    Latini, R.
    Anand, I. S.
    Ueland, T.
    Brunner-La Rocca, H. P.
    Bayes-Genis, A.
    De Boer, R. A.
    Huber, K.
    Emdin, M.
    Vergaro, G.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 869 - 869
  • [4] Prognostic value of sST2 in heart failure patients with diabetes
    Castiglione, V.
    Chiriaco, M.
    Aimo, A.
    Januzzi, J.
    Richards, A. M.
    Lam, C. S. P.
    Latini, R.
    Anand, I. S.
    Ueland, T.
    Brunner-La Rocca, H. P.
    Bayes-Genis, A.
    De Boer, R. A.
    Huber, K.
    Emdin, M.
    Vergaro, G.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 101 - 102
  • [5] Prognostic value of coronary calcifications for cardiovascular events in patients with diabetes mellitus
    Becker, A
    Knez, A
    Becker, C
    Leber, A
    Haberl, R
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 : 569 - 569
  • [6] Prognostic value of coronary calcifications for cardiovascular events in patients with diabetes mellitus
    Becker, A
    Knez, A
    Leber, AW
    Thilo, C
    Haberl, R
    Steinbeck, G
    [J]. CIRCULATION, 2001, 104 (17) : 536 - 536
  • [7] Determinants and Prognostic Value of Cardiovascular Autonomic Function in Coronary Artery Disease Patients With and Without Type 2 Diabetes
    Karjalainen, Jaana J.
    Kiviniemi, Antti M.
    Hautala, Arto J.
    Piira, Olli-Pekka
    Lepojarvi, E. Samuli
    Peltola, Mirja A.
    Ukkola, Olavi H.
    Hedberg, Pirjo S. M.
    Huikuri, Heikki V.
    Tulppo, Mikko Paavo
    [J]. DIABETES CARE, 2014, 37 (01) : 286 - 294
  • [8] Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus
    Hammer, Fabian
    Genser, Bernd
    Dieplinger, Benjamin
    Egger, Margot
    Mueller, Thomas
    Drechsler, Christiane
    Maerz, Winfried
    Stoerk, Stefan
    Wanner, Christoph
    Krane, Vera
    [J]. CLINICAL KIDNEY JOURNAL, 2022, 15 (10) : 1915 - 1923
  • [9] Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease
    Ndrepepa, Gjin
    Braun, Siegmund
    King, Lamin
    Cassese, Salvatore
    Tada, Tomohisa
    Fusaro, Massimiliano
    Hadamitzky, Martin
    Haase, Hans-Ullrich
    Schoemig, Albert
    Kastrati, Adnan
    [J]. CLINICAL SCIENCE, 2013, 124 (3-4) : 259 - 268
  • [10] Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss
    Simeone, Paola
    Tripaldi, Romina
    Michelsen, Annika
    Ueland, Thor
    Liani, Rossella
    Ciotti, Sonia
    Birkeland, Kare I.
    Gulseth, Hanne L.
    Di Castelnuovo, Augusto
    Cipollone, Francesco
    Aukrust, Pal
    Consoli, Agostino
    Halvorsen, Bente
    Santilli, Francesca
    [J]. CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)